Cargando…
COVID19 biomarkers: What did we learn from systematic reviews?
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial public health concern. It can rapidly progress to severe disease, with poor prognosis and a high mortality risk. An early diagnosis and specific prognostic tools can help healthcare providers to start interventions...
Autor principal: | Semiz, Sabina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792992/ https://www.ncbi.nlm.nih.gov/pubmed/36583110 http://dx.doi.org/10.3389/fcimb.2022.1038908 |
Ejemplares similares
-
Circadian Rhythms in Bacterial Sepsis Pathology: What We Know and What We Should Know
por: Mul Fedele, Malena Lis, et al.
Publicado: (2021) -
Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019) -
Metabolic and Microbial Changes Associated With Diet and Obesity During Pregnancy: What Can We Learn From Animal Studies?
por: Dreisbach, Caitlin, et al.
Publicado: (2022) -
A Review on Host-Leptospira Interactions: What We Know and Future Expectations
por: Daroz, Brenda B., et al.
Publicado: (2021) -
Bacterial Vaginosis: What Do We Currently Know?
por: Abou Chacra, Linda, et al.
Publicado: (2022)